NCT02238652

Brief Summary

Improving quality of life (QoL) in residents of nursing homes: A cluster randomized clinical trial of efficacy - The KOSMOS study. COSMOS (COmmunication (Advance Care Planning - ACP), Systematic pain assessment and treatment, Medication review, Occupational therapy, and Safety) is a practical intervention aimed to improve clinical and psychiatric challenges in NH patients. The COSMOS intervention combines the most effective research results to improve staff competence and patients' mental health, safety, QoL. We also aim to reduce psychotropic drug use and costs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
560

participants targeted

Target at P75+ for not_applicable quality-of-life

Timeline
Completed

Started Aug 2014

Geographic Reach
1 country

32 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2014

Completed
25 days until next milestone

Study Start

First participant enrolled

August 1, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 12, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

April 15, 2016

Status Verified

September 1, 2014

Enrollment Period

1.3 years

First QC Date

July 7, 2014

Last Update Submit

April 14, 2016

Conditions

Keywords

Nursing homesDementiaQuality of LifeGeriatricsAgedActivities of Daily LivingPainPain managementAdvance Care PlanningPatient SafetyCosts and Cost AnalysisMedication ErrorsMedical Order Entry SystemsMedication ReconciliationMedication Therapy ManagementDepressionPsychotropic DrugsInformed ConsentPresumed ConsentAnxietyApathyHospitalizationMortality

Outcome Measures

Primary Outcomes (2)

  • Neuropsychiatric symptoms

    Depression, anxiety an apathy will be assessed by the Neuropsychiatric Inventory - Nursing Home version (NPI-NH).

    9 months

  • Quality of life

    Assessing quality of life by Qualidem, QUALID and EQ-5D.

    9 months

Secondary Outcomes (11)

  • Activities of daily living

    9 months

  • Mood or depression

    9 months

  • Pain

    9 months

  • Medication review

    9 months

  • Drug-related problems

    9 months

  • +6 more secondary outcomes

Other Outcomes (1)

  • Implementation indicators

    9 months

Study Arms (2)

Control

NO INTERVENTION

Intervention

ACTIVE COMPARATOR

Communication Systematic Pain Assessment and Treatment Medication Review Occupational therapy Safety

Behavioral: CommunicationBehavioral: Systematic Pain Assessment and TreatmentBehavioral: Medication ReviewBehavioral: Occupational therapyBehavioral: Safety

Interventions

CommunicationBEHAVIORAL

A preparation process before the patient become incapable of participating in life prolonging decisions

Also known as: advance care planning
Intervention

Assess pain with MOBID-2 Pain Scale and thereby improve pain management in dementia.

Also known as: MOBID-2
Intervention

An individual and systematic review of medication prescriptions to identify possible harmful drug effects and to reduce the use of psychotropic drugs.

Intervention

Increase individual activities, based on function, personal interest and personality by educating the staff on these elements.

Intervention
SafetyBEHAVIORAL

Focusing on developing a culture where staff has an active and constant awareness of how to prevent adverse events and a commitment to safety.

Also known as: patient safety
Intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Resident in long time care ward in Bergen, Bærum, Sarpsborg, Kvam, Fjell, Sund, Askøy and Øygarden

You may not qualify if:

  • Dying patients with reduced consciousness at baseline
  • Active Schizophrenia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (32)

Solvik

Baerum, Akershus, 1304, Norway

Location

Donski Bo og behandlingssenter

Baerum, Akershus, 1346, Norway

Location

Mariehaven Bo og behandlingssenter

Baerum, Akershus, 1346, Norway

Location

Berger Bo og Behandlingssenter

Baerum, Akershus, 1349, Norway

Location

Kolaashjemmet Bo og Behandlingssenter

Baerum, Akershus, 1352, Norway

Location

Gullhaug Bo og behandlingssenter

Baerum, Akershus, 1354, Norway

Location

Osteraas Bo og behandlingssenter

Baerum, Akershus, 1361, Norway

Location

Solbakken Bo og Behandlingssenter

Baerum, Akershus, 1361, Norway

Location

Lønnås Bo og Rehabsenter

Baerum, Akershus, 1362, Norway

Location

Nordraaksvei bo og behandlingssenter

Baerum, Akershus, 1369, Norway

Location

Stabaekktunet Bo og behandlingssenter

Baerum, Akershus, 1369, Norway

Location

Stabekk Bo og Behandlingssenter

Baerum, Akershus, 1369, Norway

Location

Ask bo og omsorgssenter

Askøy, Norway

Location

Arna helseheim

Bergen, Norway

Location

Frieda Fasmers minne

Bergen, Norway

Location

Gullstøltunet Sykehjem

Bergen, Norway

Location

Hospitalet Betanien

Bergen, Norway

Location

Lyngbøtunet Bo og servicesenter

Bergen, Norway

Location

Slettebakken menighets eldresenter

Bergen, Norway

Location

University of Bergen

Bergen, Norway

Location

Strandebarmheimen

Kvam, Norway

Location

Toloheimen

Kvam, Norway

Location

Øysteseheimen

Kvam, Norway

Location

Borgen sykehjem

Sarpsborg, Norway

Location

Eplehagen bofellesskap

Sarpsborg, Norway

Location

Haugvoll sykehjem

Sarpsborg, Norway

Location

Helsehuset

Sarpsborg, Norway

Location

Kurland

Sarpsborg, Norway

Location

Tingvoll sykehjem

Sarpsborg, Norway

Location

Valaskjold omsorgssenter

Sarpsborg, Norway

Location

Sundheimen

Sund, Norway

Location

Tednebakkane omsorgssenter

Øygarden, Norway

Location

Related Publications (10)

  • Husebo BS, Flo E, Aarsland D, Selbaek G, Testad I, Gulla C, Aasmul I, Ballard C. COSMOS--improving the quality of life in nursing home patients: protocol for an effectiveness-implementation cluster randomized clinical hybrid trial. Implement Sci. 2015 Sep 15;10:131. doi: 10.1186/s13012-015-0310-5.

    PMID: 26374231BACKGROUND
  • Vislapuu M, Berge LI, Angeles RC, Kjerstad E, Mannseth J, Achterberg WP, Husebo BS. Factors associated with formal and informal resource utilization in nursing home patients with and without dementia: cross-sectional analyses from the COSMOS trial. BMC Health Serv Res. 2022 Nov 2;22(1):1306. doi: 10.1186/s12913-022-08675-y.

  • Flo-Groeneboom E, Elvegaard T, Gulla C, Husebo BS. The longitudinal association between the use of antihypertensive medications and 24-hour sleep in nursing homes: results from the randomized controlled COSMOS trial. BMC Geriatr. 2021 Jul 18;21(1):430. doi: 10.1186/s12877-021-02317-4.

  • Gedde MH, Husebo BS, Mannseth J, Kjome RLS, Naik M, Berge LI. Less Is More: The Impact of Deprescribing Psychotropic Drugs on Behavioral and Psychological Symptoms and Daily Functioning in Nursing Home Patients. Results From the Cluster-Randomized Controlled COSMOS Trial. Am J Geriatr Psychiatry. 2021 Mar;29(3):304-315. doi: 10.1016/j.jagp.2020.07.004. Epub 2020 Jul 11.

  • de Jong-Schmit BEM, Poortvliet RKE, Bohringer S, Bogaerts JMK, Achterberg WP, Husebo BS. Blood pressure, antihypertensive medication and neuropsychiatric symptoms in older people with dementia: The COSMOS study. Int J Geriatr Psychiatry. 2021 Jan;36(1):46-53. doi: 10.1002/gps.5388. Epub 2020 Oct 8.

  • Gulla C, Flo E, Kjome RLS, Husebo BS. Implementing a novel strategy for interprofessional medication review using collegial mentoring and systematic clinical evaluation in nursing homes (COSMOS). BMC Geriatr. 2019 May 7;19(1):130. doi: 10.1186/s12877-019-1139-6.

  • Habiger TF, Achterberg WP, Flo E, Husebo BS. Psychosis symptoms in nursing home residents with and without dementia-Cross-sectional analyses from the COSMOS study. Int J Geriatr Psychiatry. 2019 May;34(5):683-691. doi: 10.1002/gps.5067. Epub 2019 Mar 4.

  • Aasmul I, Husebo BS, Sampson EL, Flo E. Advance Care Planning in Nursing Homes - Improving the Communication Among Patient, Family, and Staff: Results From a Cluster Randomized Controlled Trial (COSMOS). Front Psychol. 2018 Dec 4;9:2284. doi: 10.3389/fpsyg.2018.02284. eCollection 2018.

  • Aasmul I, Husebo BS, Flo E. Description of an advance care planning intervention in nursing homes: outcomes of the process evaluation. BMC Geriatr. 2018 Jan 25;18(1):26. doi: 10.1186/s12877-018-0713-7.

  • Blytt KM, Bjorvatn B, Husebo B, Flo E. Clinically significant discrepancies between sleep problems assessed by standard clinical tools and actigraphy. BMC Geriatr. 2017 Oct 27;17(1):253. doi: 10.1186/s12877-017-0653-7.

Related Links

MeSH Terms

Conditions

DementiaPainAgnosiaDepressionAnxiety DisordersLethargy

Interventions

Advance Care PlanningTherapeuticsMedication ReviewOccupational TherapySafetyPatient Safety

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Patient Care PlanningComprehensive Health CarePatient Care ManagementHealth Services AdministrationMedication SystemsOrganization and AdministrationRehabilitationAftercareContinuity of Patient CarePatient CareAccident PreventionAccidentsPublic HealthEnvironment and Public Health

Study Officials

  • Bettina S. Husebø, MD, PhD

    University of Bergen

    STUDY DIRECTOR
  • Elisabeth Flo, PysD, PhD

    University of Bergen

    PRINCIPAL INVESTIGATOR
  • Irene Aasmul, Master

    University of Bergen

    PRINCIPAL INVESTIGATOR
  • Christine Gulla, MD

    University of Bergen

    PRINCIPAL INVESTIGATOR
  • Torstein Habiger

    University of Bergen

    PRINCIPAL INVESTIGATOR
  • Tony Elvegaard

    University of Bergen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, assoc prof.

Study Record Dates

First Submitted

July 7, 2014

First Posted

September 12, 2014

Study Start

August 1, 2014

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

April 15, 2016

Record last verified: 2014-09

Locations